Establishment and characterization of rat portal myofibroblast cell lines

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Fausther, Michel ^a,b   Goree, Jessica R ^a,b   Lavoie, Élise G ^a,b   Graham, Alicia L ^a   Sévigny, Jean ^c,d   Dranoff, Jonathan A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VA Central Arkansas Healthcare System   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

^d University Laval   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; COLLAGEN TYPE 15 ALPHA 1; ELASTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BROXURIDINE;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CELL ISOLATION; CELL LINE; CELL PROLIFERATION; CHOLANGIOCARCINOMA CELL LINE; COCULTURE; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; MYOFIBROBLAST; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RGF CELL LINE; RGF N2 CELL LINE; ANIMAL; CELL CULTURE TECHNIQUE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; LIVER; METABOLISM; PHYSIOLOGY; PORTAL VEIN; PROCEDURES;

RATTUS; RODENTIA;

ANIMALS; BIOMARKERS; BROMODEOXYURIDINE; CELL CULTURE TECHNIQUES; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; LIVER; MYOFIBROBLASTS; PORTAL SYSTEM; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84926293598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121161     Document Type: Article

References (37)

1. Wells RG. The portal fibroblast: not just a poor man's stellate cell. Gastroenterology. 2014; 147: 41-47. doi: 10.1053/j.gastro.2014.05.001 PMID: 24814904
2. Fausther M, Lavoie EG, Dranoff JA. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep. 2013; 1: 225-230. PMID: 23997993
3. Lemoinne S, Cadoret A, El Mourabit H, Thabut D, Housset C. Origins and functions of liver myofibroblasts. Biochim Biophys Acta. 2013; 1832: 948-954. doi: 10.1016/j.bbadis.2013.02.019 PMID: 23470555
4. Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, et al. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol. 2014; 5: 167. doi: 10.3389/fphar.2014.00167 PMID: 25100997
5. Dranoff JA, Wells RG. Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology. 2010; 51: 1438-1444. doi: 10.1002/hep.23405 PMID: 20209607
6. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010; 7: 425-436. doi: 10.1038/nrgastro.2010.97 PMID: 20585339
7. Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013; 4: 2823. doi: 10.1038/ncomms3823 PMID: 24264436
8. Iwaisako K, Jiang C, Zhang M, Cong M, Moore-Morris TJ, Park TJ, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A. 2014; 111: E3297-3305. doi: 10.1073/pnas. 1400062111 PMID: 25074909
9. Schnabl B, Choi YH, Olsen JC, Hagedorn CH, Brenner DA. Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab Invest. 2002; 82: 323-333. PMID: 11896211
10. Martucci RB, Ziulkoski AL, Fortuna VA, Guaragna RM, Guma FC, Trugo LC, et al. Beta-carotene storage, conversion to retinoic acid, and induction of the lipocyte phenotype in hepatic stellate cells. J Cell Biochem. 2004; 92: 414-423. PMID: 15108365
11. Guo J, Hong F, Loke J, Yea S, Lim CL, Lee U, et al. A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells. J Biol Chem. 2010; 285: 5428-5437. doi: 10.1074/jbc.M109.035295 PMID: 20022962
12. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 2000; 41: 882-893. PMID: 10828080
13. Greenwel P, Schwartz M, Rosas M, Peyrol S, Grimaud JA, Rojkind M. Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest. 1991; 65: 644-653. PMID: 1753710
14. Kruglov EA, Jain D, Dranoff JA. Isolation of primary rat liver fibroblasts. J Investig Med. 2002; 50: 179-184. PMID: 12033282
15. Wen JW, Olsen AL, Perepelyuk M, Wells RG. Isolation of rat portal fibroblasts by in situ liver perfusion. J Vis Exp. 2012.
16. Dranoff JA, Kruglov EA, Robson SC, Braun N, Zimmermann H, Sévigny J. The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology. 2002; 36: 1135-1144. PMID: 12395323
17. Dezso K, Jelnes P, Laszlo V, Baghy K, Bodor C, Paku S, et al. Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. Am J Pathol. 2007; 171: 1529-1537. PMID: 17884967
18. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012; 13: 134. doi: 10. 1186/1471-2105-13-134 PMID: 22708584
19. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, et al. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol. 1985; 1: 579-596. PMID: 4056357
20. Jhandier MN, Kruglov EA, Lavoie EG, Sevigny J, Dranoff JA. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem. 2005; 280: 22986-22992. PMID: 15799977
21. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134: 1655-1669. doi: 10. 1053/j.gastro.2008.03.003 PMID: 18471545
22. Hinz B. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast. Proc Am Thorac Soc. 2012; 9: 137-147. doi: 10.1513/pats.201202-017AW PMID: 22802288
23. Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med. 2013; 19: 1617-1624. doi: 10.1038/nm.3282 PMID: 24216753
24. Iwaisako K, Brenner DA, Kisseleva T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol. 2012; 27 Suppl 2: 65-68. doi: 10.1111/j.1440-1746.2011.07002.x PMID: 22320919
25. Bosselut N, Housset C, Marcelo P, Rey C, Burmester T, Vinh J, et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics. 2010; 10: 1017-1028. doi: 10.1002/pmic.200900257 PMID: 20049859
26. Lemoinne S, Cadoret A, Rautou PE, El Mourabit H, Ratziu V, Corpechot C, et al. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles. Hepatology. 2014.
27. Perepelyuk M, Terajima M, Wang AY, Georges PC, Janmey PA, Yamauchi M, et al. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol. 2013; 304: G605-614. doi: 10.1152/ ajpgi.00222.2012 PMID: 23328207
28. Tateaki Y, Ogawa T, Kawada N, Kohashi T, Arihiro K, Tateno C, et al. Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers. Histochem Cell Biol. 2004; 122: 41-49. PMID: 15221412
29. Mezaki Y, Morii M, Hebiguchi T, Yoshikawa K, Yamaguchi N, Miura M, et al. Differential increases in the expression of intermediate filament proteins and concomitant morphological changes of transdifferentiating rat hepatic stellate cells observed in vitro. Acta Histochem Cytochem. 2013; 46: 137-143. doi: 10.1267/ahc.13007 PMID: 24194627
30. Li Z, Dranoff JA, Chan EP, Uemura M, Sevigny J, Wells RG. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology. 2007; 46: 1246-1256. PMID: 17625791
31. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88: 125-172. doi: 10.1152/physrev.00013.2007 PMID: 18195085
32. Iwaisako K, Taura K, Koyama Y, Takemoto K, Asagiri M. Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies. Curr Pathobiol Rep. 2014; 2: 209-215. PMID: 25401051
33. Wells RG. Portal Fibroblasts in Biliary Fibrosis. Curr Pathobiol Rep. 2014; 2: 185-190. PMID: 25599013
34. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol. 2002; 36: 200-209. PMID: 11830331
35. Ijzer J, Roskams T, Molenbeek RF, Ultee T, Penning LC, Rothuizen J, et al. Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver. Comp Hepatol. 2006; 5: 7. PMID: 17109742
36. Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest. 2004; 84: 153-159. PMID: 14688800
37. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007; 170: 1807-1816. PMID: 17525249